12 Nov 2018 Avacta’s Chief Scientific Officer to Present Recent Data at Major European Conference Investors | Therapeutics
22 May 2018 Successful Outcome of “Gene Delivery” Collaboration with FIT Biotech Investors | Therapeutics
22 Jan 2018 Avacta and OncoSec to Collaborate on Innovative Gene Delivery of Therapeutic Affimers Investors | Therapeutics
15 Jan 2018 Positive Outcome of Proof-of-Concept Study with Glythera and Follow on Drug Development Partnership Investors | Therapeutics
13 Nov 2017 Avacta’s Chief Scientific Officer to Present Therapeutics Update at PEGS Europe Investors | Therapeutics
05 Oct 2017 Avacta initiates gene therapy research collaboration with FIT Biotech Oy Investors | Therapeutics
02 Oct 2017 Avacta establishes US business development team Investors | Reagents & Diagnostics | Therapeutics
03 Apr 2017 Excellent results for Affimer technology in Industry-standard immunogenicity study using human samples Investors | Therapeutics
02 Feb 2017 New video animation – An introduction to Affimer Technology Investors | Reagents & Diagnostics | Therapeutics